Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections

PHASE4CompletedINTERVENTIONAL
Enrollment

1,129

Participants

Timeline

Start Date

September 30, 1995

Primary Completion Date

October 31, 2011

Study Completion Date

May 31, 2012

Conditions
Hepatitis BVaccination
Interventions
BIOLOGICAL

Engerix-B

10 mkg per dose; 3 doses according to 0, 1, 6 month schedule; booster doses 5, 10 or 15 years post-primary vaccination.

Trial Locations (1)

G1E 7G9

Vladimir Gilca, Québec

All Listed Sponsors
collaborator

Institut National en Santé Publique du Québec

OTHER

collaborator

Centre de Recheche du Centre Hospitalier Université Laval

OTHER

collaborator

SmithKlinBeecham Biologicals

UNKNOWN

lead

Laval University

OTHER

NCT00169858 - Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections | Biotech Hunter | Biotech Hunter